Top

Drugs

Published in:

01-10-2002 | Adis New Drug Profile

Rosuvastatin

A Viewpoint by Anders C. Olsson

Author: Anders C. Olsson

Published in: Drugs | Issue 14/2002

Excerpt

The development of rosuvastatin suggests that this drug may be useful in the treatment and prevention of cardiovascular disease. Rosuvastatin is an appealing statin to the clinician in several ways. It has a marked inhibitory effect on hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase and shows an effective hepatic selectivity, unlike other HMG-CoA reductase inhibitors, which might be of importance with regard to the risk of adverse effects. In addition, it has a low propensity for pharmacokinetic drug interactions and is metabolised very slowly by hepatocytes. …

Title: Rosuvastatin
A Viewpoint by Anders C. Olsson
Author: Anders C. Olsson
Publication date: 01-10-2002
Publisher: Springer International Publishing
Published in: Drugs / Issue 14/2002
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI: https://doi.org/10.2165/00003495-200262140-00009

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Rosuvastatin

A Viewpoint by Anders C. Olsson

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 14/2002

Rosuvastatin

Valdecoxib

Premenopausal Breast Cancer

The Role of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Antagonists in the Management of Diabetic Complications

Levofloxacin

Valdecoxib